According to the IARC TP53 mutation database (https://p53.iarc.fr/), the codon 72 is one of the validated polymorphisms identified in the TP53 gene and several studies have been carried out to correlate this polymorphism with cancer risk. This evidence concerns the gene TP53 and cancer.